Sanomedics (SIMH) Annual Balance Sheets

Annual · GAAP · USD millions
Access SIMH quarterly Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Sanomedics balances growth, leverage, and shareholder equity.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2014)
(Dec 31 2013) (Dec 31 2012) (Dec 31 2011)
Assets
Cash & cash equivalent0.21
Deposit Assets0.01
Cash & Short-term Investments0.00
Accounts receivable0.24
Inventories0.02
Other Current Assets0.00
Other Prepaid Expense, Current PR0.34
Total Current Assets0.82
Equipment/Property/Plant Net0.02
Intangible Assets0.01
Other Assets, Noncurrent0.00
Total Assets0.85
Liabilities
Accounts Payable and Other Accrued Liabilities, Current0.48
Accrued Liabilities, Current1.00
Derivative Liability, Current DE2.77
Notes Payable, Current NO1.63
Other Liabilities, Current0.00
Total Current Liabilities5.88
Convertible Notes Payable, Noncurrent LO0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.02
Total Liabilities5.91
Stockholders' Equity
Stock Subscription Receivable-
Common Stock Value0.00
Common Stock, Held by Subsidiary etc.-0.02
Additional Paid In Capital Common Stock15.20
Retained Earnings / Accumulated Deficit-20.24
Other Equity0.00
Common Stockholder's Equity-5.05
Preferred Stockholder's Equity0.00
Total Stockholder's Equity-5.05
Liabilities & Stockholder's Equity0.85
4 historic quarters locked

Sign in to unlock the full Sanomedics balance sheet history.

About SIMH Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.